Scott Eggener
Overview
Explore the profile of Scott Eggener including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
2888
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoffmann T, Graff R, Madduri R, Rodriguez A, Cario C, Feng K, et al.
Nat Genet
. 2025 Feb;
57(2):334-344.
PMID: 39930085
We conducted a multiancestry genome-wide association study of prostate-specific antigen (PSA) levels in 296,754 men (211,342 European ancestry, 58,236 African ancestry, 23,546 Hispanic/Latino and 3,630 Asian ancestry; 96.5% of participants...
2.
Chatterjee A, Yousuf A, Engelmann R, Harmath C, Lee G, Medved M, et al.
Radiol Imaging Cancer
. 2025 Jan;
7(1):e240156.
PMID: 39836080
Purpose To evaluate the use of an automated hybrid multidimensional MRI (HM-MRI)-based tool to prospectively identify prostate cancer targets before MRI/US fusion biopsy in comparison with Prostate Imaging and Reporting...
3.
Ballas L, Reddy C, Han H, Makar J, Mian O, Broughman J, et al.
Pract Radiat Oncol
. 2024 Dec;
PMID: 39733964
Purpose: We evaluate prognostic factors and patterns of recurrence in patients who received RT ± androgen deprivation therapy (ADT) for pathologic node-positive (pN1) prostate cancer (PCa) in a multi-institutional cohort....
4.
Antonelli L, Heidenreich A, Bagrodia A, Amini A, Baky F, Branger N, et al.
BJU Int
. 2024 Dec;
PMID: 39662898
Objectives: To reassess the role of primary retroperitoneal lymph node dissection (RPLND) in patients with marker-negative non-seminomatous germ cell tumour (NSGCT) clinical stage (CS) 2a, to explore results in patients...
5.
6.
Ghoreifi A, Sheybaee Moghaddam F, Mitra A, Khanna A, Singh A, Chavarriaga J, et al.
Eur Urol Focus
. 2024 Nov;
PMID: 39551650
Background And Objective: The feasibility and safety of a robotic approach for postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in testicular cancer have been demonstrated, but data on long-term oncological outcomes...
7.
Chatterjee A, Fan X, Slear J, Asare G, Yousuf A, Medved M, et al.
Cancers (Basel)
. 2024 Oct;
16(20).
PMID: 39456593
This study investigates whether quantitative MRI and histology of the prostate reveal differences between races, specifically African Americans (AAs) and Caucasian Americans (CAs), that can affect diagnosis. Patients (98 CAs,...
8.
Lazarovich A, Kristof T, Steadman S, Dahmen A, Josephson M, Barth R, et al.
BJU Int
. 2024 Oct;
135(2):339-345.
PMID: 39385314
Objective: To analyse the management and outcomes of individuals diagnosed with prostate cancer either before or after organ transplantation, as the impact of organ transplantation and associated immunosuppression on the...
9.
Vigneswaran H, Eklund M, Discacciati A, Nordstrom T, Hubbard R, Perlis N, et al.
J Clin Oncol
. 2024 Jul;
42(32):3806-3816.
PMID: 39038251
Purpose: Asian, Black, and Hispanic men are underrepresented in prostate cancer (PCa) clinical trials. Few novel prostate cancer biomarkers have been validated in diverse cohorts. We aimed to determine if...
10.
Fankhauser C, Eggener S
Eur Urol Focus
. 2024 Jul;
10(3):355-356.
PMID: 39013684
No abstract available.